Chapter 13: The Nervous System
- Chapter Author-Editors
- Introduction
- 13.1 Principles of Assessment
- 13.2 Method for Rating Impairments
- 13.3 Method for Rating Impairments From Nervous System Diagnoses
- 13.4 Introduction to Diseases of the Nervous System
- The QuickView Worksheet
- 13.4a Cerebrovascular Disease
- 13.4b Neoplasms of the Nervous System
- 13.4c Epilepsy
- 13.4d Autonomic Disorders
- 13.4e External (Traumatic) Injuries to the Nervous System
- 13.4f Inflammatory Disorders, Including Multiple Sclerosis
- 13.4g Movement Disorders
- 13.4h Neurodegenerative Disorders
- 13.4i Motor Neuron Diseases or Related Disorders
- 13.4j Disorders of Cerebrospinal Fluid Pressure and Flow
- 13.4k Toxic, Metabolic and Infectious Disorders of the Nervous System
- 13.4l Diseases of Neuromuscular Junction or Muscle
- 13.4m Neuropathic Pain: Cranial and Peripheral Neuropathies, and CRPS
- Headache Disorders
- The QuickView Worksheet
- 13.5 Tables for Rating Impairments of the Nervous System
- 13.6 Summary of Nervous System Impairment Evaluation
- References
-
1.
American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Publishing; 2013.
-
2.
World Health Organization. International Classification of Functioning, Disability, and Health: ICF. World Health Organization; 2013.
-
3.
Bickenbach J, Cieza A, Selb M, Stucki G. ICF Core Sets, Manual for Clinical Practice. 2nd ed. Hogrefe Publishing; 2021.
-
4.
Lees-Haley PR, Williams CW, English LT. Response bias in self-reported history of plaintiffs compared with nonlitigating patients. Psychol Rep. 1996;79(3 pt 1):811-818. doi:10.2466/pr0.1996.79.3.811
-
5.
Don AS, Carragee EJ. Is the self-reported history accurate in patients with persistent axial pain after a motor vehicle accident? Spine J. 2009;9(1):4-12. doi:10.1016/j.spinee.2008.11.002
-
6.
Talmage J. AMA Guides to the Evaluation of Work Ability and Return to Work. 2nd ed. American Medical Association; 2011.
-
7.
Caruso G, Kertay L. Part I: psychological factors in delayed and failed recovery and unnecessary disability. AMA Guides Newsletter. 2019 May/Jun;24(3):3-9.
-
8.
Caruso G, Kertay L. Part II: psychological factors in delayed and failed recovery and unnecessary disability. AMA Guides Newsletter. 2019 July/August;24(4):3-14.
-
9.
World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioral Disorders. World Health Organization; 1993.
-
10.
World Health Organization (WHO). ICD-11: International Classification of Diseases, Eleventh Revision. World Health Organization; 2021. https://icd.who.int. Accessed September 30, 2019.
-
11.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
-
12.
Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Med J. 1965;14:56-61.
-
13.
Wade DT, Collins C. The Barthel ADL index: a standard measure of physical disability? Int Disability Stud. 1988;10:64-67.
-
14.
Edemekong PF, Bomgaars DL, Sukumaran S, Levy SB. Activities of daily living. In: StatPearls. StatPearls Publishing; May 2, 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK470404/
-
15.
Stineman MG, Streim JE, Pan Q, et al. Activity limitation stages empirically derived for activities of daily living (ADL) and instrumental ADL in the US adult community-dwelling Medicare population. PM R. 2014;6(11):976-987. doi:10.1016/j.pmrj.2014.05.001
-
16.
Morris Z, Whiteley WN, Longstreth WT, et al. Incidental findings on brain magnetic resonance imaging: a systematic review and meta-analysis. BMJ. 2009;339:b3016. doi:10.1136/bmj.b3016
-
17.
Strub RL, Black RW. Mental Status Examination in Neurology. 3rd ed. FA Davis Co; 1993.
-
18.
Holland A. The Communicative Abilities in Daily Living Manual. Pro-Ed; 1980.
-
19.
Fridriksson J, Hillis AE. Current approaches to the treatment of post-stroke aphasia. J Stroke. 2021;23(2):183-201. doi:10.5853/jos.2020.05015
-
20.
Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. Oxford University Press; 2006.
-
21.
Tariq SH, Tumosa N, Chibnall JT, et al. Comparison of the Saint Louis University Mental Status Examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder: a pilot study. Am J Geriatr Psychiatry. 2006;14(11): 900-910.
-
22.
Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61(3): 215-225.
-
23.
Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE Official Report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482.
-
24.
Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705-1713.
-
25.
International League Against Epilepsy website. Available at: https://www.epilepsydiagnosis.org/
-
26.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521. doi:10.1111/epi.13709
-
27.
Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530. doi:10.1111/epi.13670
-
28.
Fisher RS. The new classification of seizures by the International League Against Epilepsy. Curr Neurol Neurosci Rep. 2017;17(6):48. doi:10.1007/s11910-017-0758-6
-
29.
Harden C, Tomson T, Gloss D, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017;88(17):1674-1680. doi:10.1212/WNL.0000000000003685. Erratum in: Neurology. 2019;93(22):982. Erratum in: Neurology. 2020;94(9):414.
-
30.
Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000; 342:314-319. doi:10.1056/NEJM200002033420503
-
31.
Dikmen S, Machamer J, Fann JR, et al. Rates of symptom reporting following traumatic brain injury. J Int Neuropsychol Soc. 2010;16(3):401-411.
-
32.
Dikmen S, Machamer J, Temkin N. Mild traumatic brain injury: longitudinal study of cognition, functional status, and post-traumatic symptoms. J Neurotrauma. 2017;34(8):1524-1530.
-
33.
Kashluba S, Paniak C, Blake T, et al. A longitudinal, controlled study of patient complaints following treated mild traumatic brain injury. Arch Clin Neuropsychol. 2004;19(6):805-816.
-
34.
Scheenen ME, Spikman JM, de Koning ME, et al. Patients “at risk” of suffering from persistent complaints after mild traumatic brain injury: the role of coping, mood disorders, and post-traumatic stress. J Neurotrauma. 2017;34(1):31-37.
-
35.
McCrea MA, Giacino JT, Barber J, et al. Functional outcomes over the first year after moderate to severe traumatic brain injury in the Prospective, Longitudinal TRACK-TBI Study. JAMA Neurol. 2021;78(8):982-992.
-
36.
Lucas RM, McMichael AJ. Public Health Classics: Association or causation; evaluating links between “environment and disease.” Bull World Health Org. 2005;83,(10):792-296. Original article, Hill AB; The environment and disease: association or causation? Proc R Soc Med. 1965:58:295-300, republished with permission of the Royal Society of Medicine.
-
37.
Wan MJ, Nomura H, Tator CH. Conversion to symptomatic Chiari I malformation after minor head or neck trauma. Neurosurgery. 2008;63(4):748-753. doi:10.1227/01.NEU.0000325498.04975.C0
-
38.
ASIA International Standards Committee, Expedited Exam Subcommittee. Available at: https://asia-spinalinjury.org/wp-content/uploads/2020/01/expedited-isncsciI-exam-feb-2020-version-1.pdf
-
39.
PVA: Paralyzed Veterans of America. Clinical practice guidelines. Available at: https://pva.org/research-resources/publications/clinical-practice-guidelines/
-
40.
Ropper AH, Samuels MA, Klein JP. Adams and Victor’s Principles of Neurology. 10th ed, McGraw-Hill Education; 2014.
-
41.
Lucchini RG, Hashim D. Tremor secondary to neurotoxic exposure: mercury, lead, solvents, pesticides. Handb Clin Neurol. 2015;131:241-249. doi:10.1016/B978-0-444-62627-1.00014-7
-
42.
Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599-1606.
-
43.
Dyck PJ, Boes CJ, Mulder D, et al. History of standard scoring, notation, and summation of neuromuscular signs: a current survey and recommendation. J Peripher Nerv Syst. 2005;10(2):158-173.
-
44.
Hoffman EM, Staff NP, Robb JM, et al. Impairments and comorbidities of polyneuropathy revealed by population-based analyses. Neurology. 2015;84(16):1644-1651. doi:10.1212/WNL.0000000000001492
-
45.
Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5-20. doi:10.1007/s10654-015-0094-6
-
46.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018:38(1):1-211. doi:10.1177/0333102417738202
-
47.
Barth RJ, Meyers JE. Rating cognitive impairment, part 2: objective and evidence-based integration of neuropsychology testing. AMA Guides Newsletter. 2017;22(2): 6-12.
-
48.
Walton J, Gilliatt RW, Hutchinson M, et al, eds. Aids to the Examination of the Peripheral Nervous System. 4th ed. Bailliere Tindall; 2000.
-
49.
Graham RC, Hughes RA. Clinimetric properties of a walking scale in peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2006;77:977-979. doi:10.1136/jnnp.2005.081497
-
50.
Graham RC, Hughes RA. Modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77:973-976. doi:10.1136/jnnp.2005.081547
-
51.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2. Erratum in: Lancet. 2017;390(10106):e38.
-
52.
Holmes WF, MacGregor EA, Dodick D. Migraine-related disability: impact and implications for sufferers’ lives and clinical issues. Neurology. 2001;56:S13-S19.
-
53.
Breslau N, Rasmussen BK. The impact of migraine: epidemiology, risk factors, and co-morbidities. Neurology. 2001;56:S4-S12.
-
54.
Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11:379-394.
-
55.
Calhoun AH, Ford S, Millin C, et al. The prevalence of neck pain in migraine. Headache. 2010; 50(8):1273-1277.
-
56.
Charles A. Migraine. New Engl J Med. 2017;377(6):553-561. doi:10.1056/NEJMcp1605502
-
57.
Lempert T, von Brevern M. Vestibular migraine. Neurol Clin. 2019;37:(4):695-706. doi:10.1016/j.ncl.2019.06.003
-
58.
Rota E, Zucco R, Guerzoni S, et al. Migraine awareness in Italy and the myth of “cervical Arthrosis.” Headache. 2020;60:81-89. doi:10.1111/head.13679
-
59.
Lipton RB, Dodick D, Sadovsky R, et al; ID Migraine validation study. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61(3):375-82. doi:10.1212/01.wnl.0000078940.53438.83
-
60.
Ligthart L, Nyholt DR, Penninx BWJH, et al. The shared genetics of migraine and anxious depression. Headache. 2010;50:1549-1560.
-
61.
Burch RC, Buse DC, Lipton RB. Migraine, epidemiology, burden and comorbidity. Neurol Clin. 2019;37:631–649. doi:10.1016/j.ncl.2019.06.001
-
62.
Robbins MS. Diagnosis and management of headache: a review. JAMA. 2021;325(18):1874-1885. doi:10.1001/jama.2021.1640
-
63.
Houts CR, Wirth RJ, McGinley JS, et al. Content validity of HIT-6 as a measure of headache impact in people with migraine: a narrative review. Headache J Head Face Pain. 2020;60(1):28-39.
-
64.
Stewart WF, Lipton RB, Dowson AJ, et al. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56:S20-S28.
-
65.
Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ version 2.1). Headache J Head Face Pain. 2000;40:204-216. doi:10.1046/j.1526-4610-2000-00030.x
-
66.
D’Amico D, Tepper SJ, Guastafierro E, et al. Mapping assessments instruments for headache disorders against the ICF Biopsychosocial Model of Health and Disability. Int J Environ Res Public Health. 2021;18(1):246. doi:10.3390/ijerph18010246
-
67.
Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1). Headache. 2000;40(3):204-215. doi:10.1046/j.1526-4610.2000.00030.x
-
68.
American Medical Association. ICD-10-CM 2022: The Complete Official Codebook With Guidelines. 1st ed. American Medical Association Press; 2021.
-
69.
American Spinal Cord Injury Association (ASIA) Impairment Scale. Physiopedia website. Accessed October 21, 2022. Available at: https://www.physio-pedia.com/American_Spinal_Cord_Injury_Association_(ASIA)_Impairment_Scale
-
70.
Castelli G, Desai KM, Cantone RE. Peripheral neuropathy: evaluation and differential diagnosis. Am Fam Physician. 2020;102(12):732-739.
-
71.
Chen DY, Chen CC, Crawford JR, Wang SG. Tumor-related epilepsy: epidemiology, pathogenesis and management. J Neurooncol. 2018;139(1):13-21. doi:10.1007/s11060-018-2862-0
-
72.
Demeter SL. Burden of treatment compliance as an impairment rating metric. Phys Med Rehabil Clin N Am. 2019;30(3):581-587.
-
73.
GBD 2017 US Neurological Disorders Collaborators. Burden of neurological disorders across the US from 1990-2017: a global burden of disease study. JAMA Neurol. 2021;78(2):165-176. doi:10.1001/jamaneurol.2020.4152
-
74.
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology. 2021;23(8):1231-1251.
-
75.
Riney K, Bogacz A, Somerville E, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1443-1474. doi:10.1111/epi.17240
-
76.
Simel DL, Rennie D. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. McGraw-Hill Education; 2008.
-
77.
Wallace SJ, Worrall L, Rose T, et al. Using the International Classification of Functioning, Disability, and Health to identify outcome domains for a core outcome set for aphasia: a comparison of stakeholder perspectives. Disabil Rehabil. 2019;41(5):564-573. doi:10.1080/09638288.2017.1400593
-
78.
Wirrell EC, Nabbout R, Scheffer IE, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1333-1348. doi:10.1111/epi.17237
-
79.
Wirrell E, Tinuper P, Perucca E, et al. Introduction to the epilepsy syndrome papers. Epilepsia. 2022;63(6):1330-1332. doi:10.1111/epi.17262
-
80.
World Health Organization. How to Use the ICF: A Practical Manual for Using the International Classification of Functioning, Disability and Health. Exposure draft for comment. 2013. World Health Organization.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 141 | 141 | 131 |
